FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular, to a formulation, a pharmaceutical composition, and a medicinal product having nootropic activity. Claimed composition contains N-carbamoylmethyl-4-phenyl-2-pyrrolidone and 4-phenylpyrrolidone-2.
EFFECT: implementation of the invention makes it possible to obtain a pharmaceutical composition and a drug having an increased stability as compared with the fonturacetam, an increased dissolution rate and a reduced hygroscopicity.
5 cl, 6 tbl, 11 ex
Authors
Dates
2019-08-01—Published
2017-08-15—Filed